We report the first case of MDS/MPN-SF3B1-T harboring concurrent SF3B1 p.K700E, ASXL1 p.G646Wfs*12, JAK2 p.R683G, and CBL p.R149Q mutations. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.